CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2006; 56:213-225
doi: 10.3322/canjclin.56.4.213
© 2006 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Diagnostic Approach and Management of Lynch Syndrome (hereditary nonpolypos...
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendriks, Y. M.C.
Right arrow Articles by Bröcker-Vriends, A. H.J.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendriks, Y. M.C.
Right arrow Articles by Bröcker-Vriends, A. H.J.T.


ARTICLES

Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians1

Yvonne M.C. Hendriks, MD, PhD, Andrea E. de Jong, MD, Hans Morreau, MD, PhD, Carli M.J. Tops, PhD, Hans F. Vasen, MD, PhD, Juul Th. Wijnen, PhD, Martijn H. Breuning, MD, PhD and Annette H.J.T. Bröcker-Vriends, MD, PhD


Dr. Hendriks is Specialist Registrar in Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Dr. de Jong is Specialist Registrar in Gastroenterology, Netherlands Foundation of the Detection of Hereditary Tumours, Leiden, the Netherlands.
Prof. Morreau is Pathologist, Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Dr. Tops is Molecular Geneticist, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Dr. Vasen is Director of the Netherlands Foundation of the Detection of Hereditary Tumours, and Internist, Department of Gastroenterology, Leiden University Medical Center, Leiden, the Netherlands.
Dr. Wijnen is Molecular Geneticist, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Prof. Breuning is Clinical Geneticist and Head of the Center of Human and Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Dr. Bröcker-Vriends is Clinical Geneticist, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

    ABSTRACT

ABSTRACT The patient with a family history for colorectal carcinoma constitutes a complicated diagnostic challenge involving many clinicians. The diagnostic workup of familial colorectal cancer is an elaborate and time consuming process in which the family and several medical specialists closely collaborate. However, establishing a diagnosis can be very rewarding. If a mutation is detected in the family, a satisfactory explanation can be provided for an accumulation of tumors at young age, and often of untimely death. Appropriate presymptomatic testing can be offered to reduce mortality among at-risk family members, and relatives not at risk can avoid uncertainty and needlessly intensive surveillance.

We show the differential diagnostic considerations when an individual with a family history of colorectal carcinoma is encountered, with emphasis on Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma [HNPCC]). Practical recommendations for laboratory workup of suspected Lynch syndrome, including analysis of tumor tissue by microsatellite instability analysis and immunohistochemistry, and germline DNA analysis are given. Furthermore, the clinical management after a molecular diagnosis has been made is described. The diagnostic scheme presented here allows efficient and effective analysis of colorectal carcinoma cases with (suspected) Lynch syndrome, making optimal use of currently available technology.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A Canney, K Sheahan, D Keegan, M Tolan, J Hyland, and A Green
Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation
J. Clin. Pathol., May 1, 2009; 62(5): 471 - 473.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem., December 1, 2008; 54(12): e11 - e79.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
E. L. Kurnat-Thoma
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses
Biol Res Nurs, January 1, 2008; 9(3): 185 - 199.
[Abstract] [PDF]


Home page
JAMAHome page
N. M. Lindor, G. M. Petersen, D. W. Hadley, A. Y. Kinney, S. Miesfeldt, K. H. Lu, P. Lynch, W. Burke, and N. Press
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
JAMA, September 27, 2006; 296(12): 1507 - 1517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by American Cancer Society.